Clinical significance of providencia bacteremia or bacteriuria

Korean Journal of Internal Medicine

Volumn 30, Issue 2, 2015, Pages 167-169

  Wie, Seong Heon ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; ISEPAMICIN; PIPERACILLIN PLUS TAZOBACTAM; UREASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; BACTERIURIA; CATHETER COMPLICATION; CATHETER INFECTION; CATHETER MALFUNCTION; CHRONIC DISEASE; EDITORIAL; GRAM NEGATIVE SEPSIS; HOSPITAL INFECTION; HUMAN; INCIDENCE; INDWELLING URINARY CATHETER; INFECTION CONTROL; LONG TERM CARE; MIXED INFECTION; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; NURSING HOME PATIENT; PROVIDENCIA; PROVIDENCIA RETTGERI; PROVIDENCIA STUARTII; URINARY TRACT INFECTION; UROLITHIASIS; BACTEREMIA; CROSS INFECTION; ENTEROBACTERIACEAE INFECTION; FEMALE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; TERTIARY CARE CENTER;

BACTEREMIA; CROSS INFECTION; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MALE; PROVIDENCIA; TERTIARY CARE CENTERS;

EID: 84924369804     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2015.30.2.167     Document Type: Editorial

References (11)

1. Armbruster CE, Smith SN, Yep A, Mobley HL. Increased incidence of urolithiasis and bacteremia during Proteus mirabilis and Providencia stuartii coinfection due to synergistic induction of urease activity. J Infect Dis 2014;209:1524-1532.
2. Hawkey PM. Providencia stuartii: a review of a multiply antibiotic-resistant bacterium. J Antimicrob Chemother 1984;13:209-226.
3. Warren JW. Providencia stuartii: a common cause of antibiotic-resistant bacteriuria in patients with long-term indwelling catheters. Rev Infect Dis 1986;8:61-67.
4. Jones BD, Mobley HL. Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection. Infect Immun 1987;55:2198-2203.
5. Darouiche RO. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis 2001;33:1567-1572.
6. Dealler SF, Hawkey PM, Millar MR. Enzymatic degradation of urinary indoxyl sulfate by Providencia stuartii and Klebsiella pneumoniae causes the purple urine bag syndrome. J Clin Microbiol 1988;26:2152-2156.
7. Al-Jubouri MA, Vardhan MS. A case of purple urine bag syndrome associated with Providencia rettgeri. J Clin Pathol 2001;54:412.
8. O’Hara CM, Brenner FW, Miller JM. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev 2000;13:534-546.
9. Tumbarello M, Citton R, Spanu T, et al. ESBL-producing multidrug-resistant Providencia stuartii infections in a university hospital. J Antimicrob Chemother 2004;53:277-282.
10. Barrios H, Garza-Ramos U, Reyna-Flores F, et al. Isolation of carbapenem-resistant NDM-1-positive Providencia rettgeri in Mexico. J Antimicrob Chemother 2013;68:1934-1936.
11. Choi HK, Kim YK, Kim HY, Park JE, Uh Y. Clinical and microbiological features of Providencia bacteremia: experience at a tertiary care hospital. Korean J Intern Med 2015;30:219-225.